News | April 22, 2009

HRS Reiterates Positive Correlation Between EP Certification, Improved ICD Outcomes

April 22, 2009 – In response to the article “Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator,” published in the April 22 issue of the JAMA, the Heart Rhythm Society reiterates its position on the positive correlation between electrophysiology certification and improved outcomes following ICD implantation.

The study used cases submitted to the ICD Registry, which was created by the Heart Rhythm Society and the American College of Cardiology Foundation to collect detailed information on ICD implantations to assess and improve the care of patients receiving ICDs for primary prevention therapy.

The authors compared patient outcomes based on the certification status of the implanting physician: electrophysiologist, non-electrophysiologist cardiologist, thoracic surgeon and other specialists. Overall implantations by a non-electrophysiologist were associated with a higher risk of procedural complications compared to ICDs implanted by an electrophysiologist. Patients of non-electrophysiologists were also less likely to receive a CRT-D device when indicated compared to patients of electrophysiologists.

“This important study confirms the Society’s position that trained and experienced electrophysiologists are best equipped to provide optimal care for patients who need life-saving ICD or CRT-D therapy,” said N.A. Mark Estes, president of the Heart Rhythm Society. “Specialized training enables physicians to not only implant devices with a lower risk of procedural complications, but also select the most appropriate device-based therapy for each patient.”

The analysis also examined the geographic distribution of ICD implants, and found that the majority of ICD implants performed by nonelectrophysiologists took place at or relatively near hospitals in which an electrophysiologist also implanted ICDs.

The Heart Rhythm Society strongly recommends that all physicians and credentialing bodies follow the training guidance found in the ACC/ACP/AHA/HRS Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS) 3: Task Force 6 Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management.

For more information: http://jama.ama-assn.org/cgi/content/full/301/16/1661, www.hrsonline.org

Related Content

Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init